0001181431-13-036345.txt : 20130621 0001181431-13-036345.hdr.sgml : 20130621 20130621175903 ACCESSION NUMBER: 0001181431-13-036345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130620 FILED AS OF DATE: 20130621 DATE AS OF CHANGE: 20130621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORONADO BIOSCIENCES INC CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 24 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 24 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisman Harlan F CENTRAL INDEX KEY: 0001555563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 13928175 MAIL ADDRESS: STREET 1: C/O CORONADO BIOSCIENCES, INC. STREET 2: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rrd384186.xml FORM 4 X0306 4 2013-06-20 0 0001429260 CORONADO BIOSCIENCES INC CNDO 0001555563 Weisman Harlan F C/O CORONADO BIOSCIENCES, INC. 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 1 1 0 0 Chairman and CEO Common Stock 2013-06-20 4 P 0 10000 7.59 A 30000 D Options to purchase Common Stock 5.72 2022-08-16 Common Stock 25000 25000 D Options to purchase Common Stock 5.57 2023-01-07 Common Stock 1686590 1686590 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.54 to $7.61, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. One-third of the shares will vest on each of August 16, 2013, 2014 and 2015. One-third of the shares will vest on each of December 28, 2013, 2014 and 2015, subject to Dr. Weisman's continued employment with the Issuer. /s/ Dale Ritter, Attorney-in-Fact 2013-06-21